New Approaches Offer Hope for Replacing Beta Cells in Diabetes

June 14, 2016

(Medscape) – Two innovative new approaches to replacing pancreatic beta cells offer hope for treating both type 1 and type 2 diabetes in the future, experts say. On June 10 here at the American Diabetes Association (ADA) 2016 Scientific Sessions, David KC Cooper, MD, PhD, of the Thomas E Starzl Transplantation Institute, Pittsburgh, Pennsylvania, discussed his work on pig islet xenotransplantation using genetically engineered donor pigs, and Chad A Cowan, PhD, of the Harvard Stem Cell Institute, Boston, Massachusetts, spoke about universal donor stem cells created via a technique called “gene editing.”